Table 2.
Impact of T. gondiiparasitemia in laboratory characteristics of CHC patients
| Variables | CHC patients | P value | |
|---|---|---|---|
| Negative T. gondii | Positive T. gondii | ||
| AST (U/L) | 46.2 ± 18.3 | 70.4 ± 25.1 | 0.006 |
| ALT (U/L) | 44.7 ± 17.9 | 72.8 ± 27.8 | 0.005 |
| Albumin (g/dL) | 3.9 ± 0.1 | 2.9 ± 0.3 | 0.011 |
| Bilirubin (mg/dL) | 1.3 ± 0.1 | 2.3 ± 0.2 | 0.016 |
| Platelet count (x109/L) | 216.5 ± 39.1 | 111.5 ± 15.9 | 0.002 |
| AFP (U/L) | 16.2 ± 1.8 | 28.2 ± 5.4 | 0.025 |
Data were expressed as mean ± SD. Significant difference was determined using student t test. P < 0.05 is significant. CHC chronic hepatitis C, AST aspartate aminotransferase, ALT alanine aminotransferase, AFP alpha fetoprotein